| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
868,994 |
|
|
Indirect Shares
|
241,951 |
|
|
| Direct
Value |
$900,729,661 |
|
|
|
Indirect Value
|
$250,787,051 |
|
|
| Total
Shares |
1,110,945 |
|
|
| Total
Value |
$1,151,516,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-10 |
868,994 |
2024-06-10 |
241,951 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
147 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-12-15 |
4 |
OE |
$20.32 |
$3,964,005 |
D/D |
195,079 |
697,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-12-15 |
4 |
D |
$380.09 |
$40,157,269 |
D/D |
(105,652) |
591,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
89,427 |
159,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,427 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-07-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
176,223 |
323,777 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-07-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
331,629 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
176,223 |
155,406 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
176,223 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-13 |
4 |
OE |
$21.92 |
$4,284,001 |
D/D |
195,438 |
786,786 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-13 |
4 |
D |
$385.08 |
$40,885,484 |
D/D |
(106,174) |
680,612 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,264 |
500,847 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
89,264 |
244,670 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-18 |
4 |
D |
$386.90 |
$99,762,165 |
D/D |
(257,850) |
422,762 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
242,150 |
486,820 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
242,150 |
847 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-02-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
86,820 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
400,000 |
400,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-07-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
299,134 |
385,954 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-07-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
299,134 |
24,643 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
101,187 |
487,141 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
101,187 |
75,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
847 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
847 |
487,988 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,211 |
484,777 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-11-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
24,643 |
0 |
0 |
- |
|
147 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
